• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

February 10, 2012: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Roster

Contents


Members

  • Steven M. Dubinett, M.D., Chair
    Professor of Medicine and Pathology
    Division of Pulmonary and Critical Care Medicine
    David Geffen School of Medicine at the
    University of California, Los Angeles
    10833 Le Conte Avenue, 37-131 CHS
    Los Angeles, CA 90095
  • Scott P. Bruder, M.D., Ph.D. *
    Senior Vice President and Chief Science and
    Technology Officer
    Becton, Dickinson & Company
    1 Becton Drive
    Franklin Lakes, NJ 07417
  • Linda A. Dahlgren, D.V.M., Ph.D., DACVS
    Associate Professor
    Department of Large Animal Clinical Sciences
    Virginia-Maryland Regional College of
    Veterinary Medicine
    Virginia Polytechnic Institute and State University
    Phase II, Duck Pond Road
    Blacksburg, VA 24061
  • Steven A. Goldman, M.D., Ph.D.
    Rykenboer Professor and Chairman
    Department of Neurology
    University of Rochester
    601 Elmwood Avenue, MRB/Box 645
    Rochester, NY 14642
  • Francis J. Hornicek, Ph.D., M.D. +
    Chief
    Orthopedic Oncology Services
    Massachusetts General Hospital
    Yawkey Building, Suite 3700
    55 Fruit Street
    Boston, MA 02114
  • Tabassum Ahsan, Ph.D.
    Assistant Professor
    Department of Biomedical Engineering
    Center for Stem Cell Research and Regenerative
    Medicine
    Tulane University
    500 Lindy Boggs
    New Orleans, LA 70118
  • Larry A. Couture, Ph.D.
    Senior Vice President
    Center for Applied Technology Development
    Beckman Research Institute
    City of Hope
    1500 E. Duarte Road
    Duarte, CA 91711
  • Evanthia Galanis, M.D.
    Professor
    Department of Molecular Medicine
    Mayo Clinic
    200 First Street SW
    Rochester, MN 55905
  • Patrick Hwu, M.D.
    Professor
    Department of Melanoma Medical Oncology
    Division of Cancer Medicine
    University of Texas M.D. Anderson Cancer Center
    1515 Holcombe Boulevard, Unit 430
    Houston, TX 77030
  • Peter L. Saltonstall**
    President
    National Organization for Rare Disorders
    55 Kenosia Avenue, PO Box 1968
    Danbury, CT 06813
  • Mei-Ling Ting Lee, Ph.D.
    Professor
    Department of Epidemiology and Biostatistics
    Biostatistics and Risk Assessment Center
    University of Maryland School of Public Health
    SPH Building 255, EPIB, Room 2234R
    College Park, MD 20742
  • Evan Y. Snyder, M.D., Ph.D.
    Professor
    Program in Stem Cells and Regenerative Biology
    Sanford-Burnham Medical Research Institute
    10901 North Torrey Pines Road, Rm. 7261
    La Jolla, CA 32037

* Industry Representative
** Consumer Representative
+ Not Attending


FDA Participants

  • Carolyn Wilson, Ph.D.
    Associate Director for Research
    Center for Biologics Evaluation and Research Food and Drug Administration
    1401 Rockville Pike, HFM-21
    Rockville, MD 20852
  • Suzanne Epstein, Ph.D.
    Associate Director for Research
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    Food and Drug Administration
    1401 Rockville Pike, HFM-730
    Rockville, MD 20852
  • Steven Bauer, Ph.D.
    Chief
    Cellular, and Tissue Therapy Branch
    Division of Cellular and Gene Therapies
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    1401 Rockville Pike, HFM 740
    Rockville, MD 20852
  • Deborah Hursh, Ph.D.
    Senior Investigator
    Cellular and Tissue Therapy Branch
    Division of Cellular and Gene Therapies
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    1401 Rockville Pike, HFM-740
    Rockville, MD 20852
  • Stephanie Simek, Ph.D.
    Deputy Director
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    Food and Drug Administration
    1401 Rockville Pike, HFM-700
    Rockville, MD 20852
  • Raj Puri, M.D., Ph.D.
    Director
    Division of Cellular and Gene Therapies
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    1401 Rockville Pike, HFM-740
    Rockville, MD 20852
  • Brenton McCright, Ph.D.
    Senior Investigator
    Cellular and Tissue Therapy Branch
    Division of Cellular and Gene Therapies
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    1401 Rockville Pike, HFM-740
    Rockville, MD 20852
  • Brian Stultz, M.S.
    Biologist
    Cellular and Tissue Therapy Branch
    Division of Cellular and Gene Therapies
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    1401 Rockville Pike, HFM-740
    Rockville, MD 20852
  • Malcolm Moos, M.D., Ph.D.
    Senior Investigator
    Cellular and Tissue Therapy Branch
    Division of Cellular and Gene Therapies
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    1401 Rockville Pike, HFM-730
    Rockville, MD 20852
  • John Thomas, Ph.D.
    Staff Scientist
    Cellular and Tissue Therapy Branch
    Division of Cellular and Gene Therapies
    Office of Cellular, Tissue and Gene Therapies
    Center for Biologics Evaluation and Research
    1401 Rockville Pike, HFM-730
    Rockville, MD 20852

FDA Administrative Staff

  • Designated Federal Officer
    Gail Dapolito
    Division of Scientific Advisors and Consultants
    Center for Biologics Evaluation and Research
    Food and Drug Administration
    1401 Rockville Pike, HFM-71
    Rockville, MD 20852
    Phone: (301) 827-1289
    E-Mail: gail.dapolito@fda.hhs.gov
  • Committee Management Specialist
    Sheryl Clark, M.B.A.
    Division of Scientific Advisors and Consultants
    Center for Biologics Evaluation and Research
    Food and Drug Administration
    1401 Rockville Pike, HFM-71
    Rockville, MD 20852
    Phone: (301) 827-2715
    E-Mail: sheryl.clark@fda.hhs.gov